nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—S1P3 pathway—GNA11—ocular cancer	0.0385	0.0385	CbGpPWpGaD
Gliclazide—VEGFA—S1P3 pathway—GNAQ—ocular cancer	0.0358	0.0358	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.0353	0.0353	CbGpPWpGaD
Gliclazide—VEGFA—Regulation of gene expression by Hypoxia-inducible Factor—EP300—ocular cancer	0.0291	0.0291	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—E2F1—ocular cancer	0.0223	0.0223	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CDK4—ocular cancer	0.0182	0.0182	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—GNA11—ocular cancer	0.0171	0.0171	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—GNA11—ocular cancer	0.0166	0.0166	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.0163	0.0163	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—GNAQ—ocular cancer	0.0159	0.0159	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—RB1—ocular cancer	0.0158	0.0158	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—GNAQ—ocular cancer	0.0154	0.0154	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.0141	0.0141	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0138	0.0138	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—MDM2—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—GNA11—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2C—ocular cancer	0.0131	0.0131	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—GNA11—ocular cancer	0.0131	0.0131	CbGpPWpGaD
Gliclazide—VEGFA—Cellular response to hypoxia—EP300—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—GNAQ—ocular cancer	0.0125	0.0125	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—H1F0—ocular cancer	0.0123	0.0123	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—GNAQ—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CCND1—ocular cancer	0.0118	0.0118	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CDKN1A—ocular cancer	0.0114	0.0114	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—TGFB1—ocular cancer	0.0108	0.0108	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—CDK2—ocular cancer	0.0107	0.0107	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—E2F2—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CCND3—ocular cancer	0.00994	0.00994	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—MYC—ocular cancer	0.00944	0.00944	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—RBBP4—ocular cancer	0.00906	0.00906	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—E2F3—ocular cancer	0.00906	0.00906	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00899	0.00899	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TFDP1—ocular cancer	0.00843	0.00843	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0083	0.0083	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—AKT1—ocular cancer	0.00803	0.00803	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.0079	0.0079	CbGpPWpGaD
Gliclazide—VEGFA—S1P3 pathway—AKT1—ocular cancer	0.00777	0.00777	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—TP53—ocular cancer	0.00775	0.00775	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00765	0.00765	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00746	0.00746	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—HRAS—ocular cancer	0.00741	0.00741	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—CDKN1B—ocular cancer	0.00699	0.00699	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR1 specific signals—AKT1—ocular cancer	0.0069	0.0069	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—HRAS—ocular cancer	0.00688	0.00688	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00688	0.00688	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—CDKN1B—ocular cancer	0.00682	0.00682	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00673	0.00673	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—TGFB1—ocular cancer	0.00663	0.00663	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CCND2—ocular cancer	0.00637	0.00637	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.0063	0.0063	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00626	0.00626	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00592	0.00592	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDK6—ocular cancer	0.00569	0.00569	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00568	0.00568	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00543	0.00543	CbGpPWpGaD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00541	0.00541	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.0054	0.0054	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—TGFB1—ocular cancer	0.00527	0.00527	CbGpPWpGaD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00525	0.00525	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00522	0.00522	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00513	0.00513	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PSPH—ocular cancer	0.00489	0.00489	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PSPH—ocular cancer	0.00475	0.00475	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CCND3—ocular cancer	0.00463	0.00463	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—HRAS—ocular cancer	0.00449	0.00449	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00446	0.00446	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TGFB1—ocular cancer	0.00445	0.00445	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—TGFB1—ocular cancer	0.00441	0.00441	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2B—ocular cancer	0.00439	0.00439	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—ocular cancer	0.00429	0.00429	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00425	0.00425	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.0042	0.0042	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—HRAS—ocular cancer	0.0041	0.0041	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—E2F1—ocular cancer	0.00403	0.00403	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—AKT1—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—AKT1—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDK2—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—GNA11—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00331	0.00331	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDK4—ocular cancer	0.00328	0.00328	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—GNAQ—ocular cancer	0.00323	0.00323	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00315	0.00315	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—HRAS—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HDAC1—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—RB1—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CCND1—ocular cancer	0.00276	0.00276	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—HRAS—ocular cancer	0.0026	0.0026	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—MDM2—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SAG—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—MDM2—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—MDM2—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—AKT1—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN1B—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—E2F5—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—E2F4—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RBL1—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—CDK2—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN1A—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CDK4—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—EP300—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—E2F3—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—HRAS—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TFDP1—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PSPH—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TGFB1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GNA11—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—AKT1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GNA11—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GNAQ—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PSPH—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—HRAS—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GNAQ—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—HRAS—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAML2—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PSPH—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GNA11—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EP300—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNA11—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—EP300—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GNAQ—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—HRAS—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNAQ—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HDAC1—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HDAC1—ocular cancer	0.000986	0.000986	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN2B—ocular cancer	0.000884	0.000884	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—ocular cancer	0.00083	0.00083	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—E2F1—ocular cancer	0.000811	0.000811	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HRAS—ocular cancer	0.000809	0.000809	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HRAS—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CDK2—ocular cancer	0.000728	0.000728	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—ocular cancer	0.000714	0.000714	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—ocular cancer	0.000701	0.000701	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00069	0.00069	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—EP300—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—EP300—ocular cancer	0.000499	0.000499	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNA11—ocular cancer	0.000497	0.000497	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MDM2—ocular cancer	0.00049	0.00049	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNAQ—ocular cancer	0.000462	0.000462	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN1B—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNA11—ocular cancer	0.000446	0.000446	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCND1—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000414	0.000414	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN1A—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—EP300—ocular cancer	0.000409	0.000409	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNA11—ocular cancer	0.000407	0.000407	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EP300—ocular cancer	0.000393	0.000393	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MYC—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HRAS—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HRAS—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Gliclazide—ALB—Metabolism—EP300—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—EP300—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—EP300—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—ocular cancer	0.0001	0.0001	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—ocular cancer	9e-05	9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—ocular cancer	8.21e-05	8.21e-05	CbGpPWpGaD
